- Home
- BVFL vs BDTX Comparison
BVFL vs BDTX Comparison
Compare BVFL & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- BDTX
- Stock Information
- Founded
- BVFL 1873
- BDTX 2014
- Country
- BVFL United States
- BDTX United States
- Employees
- BVFL N/A
- BDTX N/A
- Industry
- BVFL Savings Institutions
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BVFL Finance
- BDTX Health Care
- Exchange
- BVFL Nasdaq
- BDTX Nasdaq
- Market Cap
- BVFL 163.3M
- BDTX 181.4M
- IPO Year
- BVFL N/A
- BDTX 2020
- Fundamental
- Price
- BVFL $16.50
- BDTX $3.82
- Analyst Decision
- BVFL
- BDTX Strong Buy
- Analyst Count
- BVFL 0
- BDTX 5
- Target Price
- BVFL N/A
- BDTX $10.40
- AVG Volume (30 Days)
- BVFL 47.0K
- BDTX 904.0K
- Earning Date
- BVFL 10-17-2025
- BDTX 11-05-2025
- Dividend Yield
- BVFL N/A
- BDTX N/A
- EPS Growth
- BVFL N/A
- BDTX N/A
- EPS
- BVFL 1.05
- BDTX 0.25
- Revenue
- BVFL $38,669,000.00
- BDTX $70,000,000.00
- Revenue This Year
- BVFL N/A
- BDTX N/A
- Revenue Next Year
- BVFL N/A
- BDTX N/A
- P/E Ratio
- BVFL $15.76
- BDTX $15.26
- Revenue Growth
- BVFL 1.69
- BDTX N/A
- 52 Week Low
- BVFL $13.53
- BDTX $1.20
- 52 Week High
- BVFL $18.19
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- BVFL 56.95
- BDTX 49.08
- Support Level
- BVFL $15.84
- BDTX $3.67
- Resistance Level
- BVFL $16.98
- BDTX $4.08
- Average True Range (ATR)
- BVFL 0.42
- BDTX 0.24
- MACD
- BVFL 0.15
- BDTX -0.06
- Stochastic Oscillator
- BVFL 78.99
- BDTX 10.26
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.